Dacihep 60 mg is a medication that contains Daclatasvir as the active ingredient. Daclatasvir is an antiviral drug used in the treatment of chronic hepatitis C, specifically in combination with other antiviral agents like sofosbuvir, ribavirin, or ledipasvir.
Category | Antiviral drug |
Brand | Zydus |
Ingredient | Daclatasvir |
Prescription Required | Yes |
Strength | 60mg |
Package | 28 Tablets |
Dacihep 60 mg (containing the active ingredient Daclatasvir) works by inhibiting the replication of the hepatitis C virus (HCV) within the body. It is classified as a direct-acting antiviral (DAA) agent that targets and blocks the function of the NS5A protein.
Dacihep 60 mg offers several significant benefits for individuals with chronic hepatitis C. As a direct-acting antiviral, it targets the NS5A protein, which is crucial for the replication of the hepatitis C virus (HCV). By inhibiting this protein, Dacihep effectively reduces the viral load, helping to control and, in many cases, eliminate the virus from the body.
Dacihep 60 mg should not be taken by individuals who are allergic to Daclatasvir or any of the other ingredients in the medication. It is also not recommended for people who are co-infected with hepatitis B or those with certain liver conditions such as severe liver impairment or decompensated cirrhosis, as the safety and efficacy of Dacihep have not been well established in these populations.
Dacihep 60 mg is typically taken as a once-daily oral tablet, and it can be taken with or without food. The dosage and treatment duration depend on the specific combination therapy prescribed by your healthcare provider, as Dacihep is often used in combination with other antiviral medications such as Sofosbuvir or Ribavirin. It is important to swallow the tablet whole and not crush, chew, or split it.
There are no reviews yet.